Spiriva Capsule
Product Images NDC 50090-4248

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 29 technical images submitted to the FDA as part of the official labeling for Spiriva (NDC 50090-4248). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Image (Lbl500904248)

Label Image (Lbl500904248)
Spiriva HandiHaler 18 microgram capsules packaging label from A-S Medication Solutions. The label indicates the product is a dry powder capsule for oral inhalation, supplied as 30 capsules (3 blister cards of 10 capsules each), stored at 77 degrees Fahrenheit.*
FDA Label Image

Chemical Structure (Spiriva 01)

Chemical Structure (Spiriva 01)
FDA Label Image

Figure 1 (Spiriva 02)

Figure 1 (Spiriva 02)
A line graph comparing FEV1 (in liters) over a 12-hour period between Spiriva HandiHaler (n=202) and placebo (n=179). The graph shows FEV1 values on the y-axis and time in hours on the x-axis, illustrating higher FEV1 levels for Spiriva relative to placebo throughout the time course.*
FDA Label Image

Figure 1 (Spiriva 03)

Figure 1 (Spiriva 03)
A line graph comparing FEV1 (liters) over 12 hours between Spiriva and placebo groups. The Spiriva group (n=202) shows higher FEV1 values than the placebo group (n=179) throughout the time period, with measurements taken from -1 to 12 hours.*
FDA Label Image

Figure 2 (Spiriva 04)

Figure 2 (Spiriva 04)
A line graph comparing FEV1 (L) over time in hours for two groups: SPIRIVA (n=153) represented by triangles and Ipratropium (n=72) represented by circles. The graph shows changes in lung function from baseline through 6 hours, with SPIRIVA demonstrating higher FEV1 values over time compared to Ipratropium.*
FDA Label Image

Figure 2 (Spiriva 05)

Figure 2 (Spiriva 05)
A line graph comparing FEV1 (in liters) over time (hours) for two groups: SPIRIVA (n=153) represented by triangles and Ipratropium (n=72) represented by circles. The graph shows FEV1 values on the vertical axis and time on the horizontal axis from 0 to 6 hours.*
FDA Label Image

Figure 3 (Spiriva 06)

Figure 3 (Spiriva 06)
A line graph comparing FEV1 (forced expiratory volume in 1 second) in liters over 48 months between two groups: Tiotropium (n=2494) and Control (n=2363). Tiotropium group shows consistently higher FEV1 values than the Control group throughout the study period, with values plotted from day 30 to month 48 on the x-axis and FEV1 in liters on the y-axis.*
FDA Label Image

Figure (Spiriva 07)

Figure (Spiriva 07)
An instructional diagram showing a human profile about to swallow a capsule by mouth, with a dividing diagonal line indicating not to take the capsule orally. The right side shows a hand holding the capsule, highlighting the proper handling before inhalation.*
FDA Label Image

Figure (Spiriva 08)

Figure (Spiriva 08)
FDA Label Image

Figure (Spiriva 09)

Figure (Spiriva 09)
An instructional illustration showing a person about to swallow a capsule with their mouth open, crossed out by a diagonal line. The image advises against swallowing the capsule, likely indicating the capsule should not be taken orally but inhaled instead.*
FDA Label Image

Figure A (Spiriva 10)

Figure A (Spiriva 10)
An instructional line drawing of a hand holding a Spiriva HandiHaler device. The diagram shows the device open with seven numbered parts labeled, illustrating components such as the mouthpiece, capsule chamber, and device hinge. The image is designed to aid proper use of the inhaler device for administration of the medication Tiotropium Bromide capsules.*
FDA Label Image

Figure B (Spiriva 11)

Figure B (Spiriva 11)
Instructional illustration showing hands handling Spiriva HandiHaler capsules. The image depicts a person removing a single 18 mcg capsule of Tiotropium Bromide from a blister strip, intended for oral respiratory inhalation use.*
FDA Label Image

Figure C (Spiriva 12)

Figure C (Spiriva 12)
An illustration of a Spiriva HandiHaler capsule labeled 'TI 01,' with an arrow indicating the amount of powder contained inside the capsule. The image highlights the capsule's design related to the powder content for inhalation use.*
FDA Label Image

Figure D (Spiriva 13)

Figure D (Spiriva 13)
An instructional illustration showing a hand holding a round inhaler device with a capsule inside. An arrow points to a button or area on the side of the inhaler, likely indicating where to press or open the device for use.*
FDA Label Image

Figure E (Spiriva 14)

Figure E (Spiriva 14)
An instructional illustration showing hands demonstrating the opening of a Spiriva HandiHaler capsule device by lifting the cap away from the base. Two black arrows indicate the direction to open the cap. The image is a simple line drawing focused on the device and hands.*
FDA Label Image

Figure F (Spiriva 15)

Figure F (Spiriva 15)
Illustration showing hands opening the mouthpiece of a Spiriva HandiHaler device capsule holder to insert a capsule. The image uses arrows to indicate the motion of opening the device.*
FDA Label Image

Figure G (Spiriva 16)

Figure G (Spiriva 16)
An instructional illustration showing hands peeling off a single Spiriva HandiHaler capsule blister from a perforated strip. The strip contains multiple capsules in labeled foil packaging. The image demonstrates how to separate one capsule for use.*
FDA Label Image

Figure H (Spiriva 17)

Figure H (Spiriva 17)
Instructional diagram showing hands peeling back a foil seal on a Spiriva HandiHaler capsule blister pack. Two callouts highlight text areas on the blister, including the product name Spiriva HandiHaler and dosage strength 18 ug, along with a directive to peel back the seal for capsule removal.*
FDA Label Image

Figure I (Spiriva 18)

Figure I (Spiriva 18)
An instructional illustration showing a hand holding a Spiriva HandiHaler device with the capsule chamber open. A capsule is being dropped into the chamber above the inhaler, indicated by a downward arrow. The image demonstrates the step of placing the capsule into the HandiHaler for inhalation.*
FDA Label Image

Figure J (Spiriva 19)

Figure J (Spiriva 19)
An instructional diagram shows a hand placing a capsule into the center chamber of a Spiriva HandiHaler device. The HandiHaler is open, and an arrow points to the capsule placement area, demonstrating correct capsule insertion for use with the inhaler.*
FDA Label Image

Figure K (Spiriva 20)

Figure K (Spiriva 20)
An instructional line drawing showing a hand holding a Spiriva HandiHaler device. The illustration indicates pressing or sliding a part of the device using two arrows, one black and one white, demonstrating a step in operating the inhaler for capsule administration.*
FDA Label Image

Figure L (Spiriva 21)

Figure L (Spiriva 21)
An instructional illustration depicting a side profile of a person's mouth exhaling a mist or spray, indicated by an arrow pointing outward from the mouth, likely representing the action of inhaling or exhaling medication vapor or aerosol.*
FDA Label Image

Figure M (Spiriva 22)

Figure M (Spiriva 22)
An instructional illustration showing a person using a Spiriva HandiHaler device by placing it to their mouth and inhaling. The image highlights the proper inhalation technique with an arrow indicating airflow.*
FDA Label Image

Figure N (Spiriva 23)

Figure N (Spiriva 23)
An instructional illustration showing the side profile of a person's nose and mouth exhaling a mist or spray directed forward, indicated by a black arrow. The graphic depicts the act of inhalation or exhalation related to respiratory drug use.*
FDA Label Image

Figure O (Spiriva 24)

Figure O (Spiriva 24)
An instructional illustration showing a person using the Spiriva HandiHaler device by inhaling through the mouthpiece. The image emphasizes the correct positioning of the inhaler at the mouth for proper respiratory inhalation of the medication.*
FDA Label Image

Figure P (Spiriva 25)

Figure P (Spiriva 25)
An instructional diagram showing a hand holding a Spiriva HandiHaler device, demonstrating the action of pressing down two side buttons, indicated by black arrows pointing inward. This image depicts a step in preparing or using the Spiriva HandiHaler capsule for inhalation.*
FDA Label Image

Figure Q (Spiriva 26)

Figure Q (Spiriva 26)
An instructional illustration showing a hand holding a Spiriva HandiHaler device. The image highlights a pressing action on the bottom part of the device, indicated by two black arrows pointing downward, demonstrating part of the inhalation process for the tiotropium bromide capsule.*
FDA Label Image

Figure R (Spiriva 27)

Figure R (Spiriva 27)
An instructional diagram showing a hand holding an inhaler device with an inserted capsule. An arrow points to the capsule, and a water faucet icon above indicates rinsing or washing. The image illustrates part of the usage or maintenance of the Spiriva HandiHaler inhalation device.*
FDA Label Image

Figure (Spiriva 28)

Figure (Spiriva 28)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.